Over 150 scientists from the University of Oxford are driving forward research into COVID-19, including development of a vaccine, drugs, antibody testing and contact tracing systems.
Now, in COVID Conversations, you can hear directly from them in a series of short talks on their work, along with a chance to ask them any questions you have about how COVID-19 research is progressing.
If you’d like to ask a question during the talk, you can do that through YouTube itself when the talk begins (you’ll need a Google/YouTube account), or on Twitter @UniofOxford with the hashtag #CovidConversations. You can also email our dedicated COVID Conversations account to submit a question in advance of each session.
These talks will be available immediately after the broadcast via the links below.
Talk 1: How Oxford is tackling COVID-19 with Professor Gavin Screaton
This talk was broadcast on Wednesday 6 May.
Watch the recording: https://youtu.be/9KoHy3RcNH4
Researchers across the University of Oxford are at the forefront of global efforts to understand the coronavirus (COVID-19) and protect our communities. In this talk, Professor Gavin Screaton, Head of Oxford’s Medical Sciences Division, gives an update on the latest achievements across a range of areas, from serology, to drug discovery, to clinical trials and vaccine creation.
Talk 2: Viral pathogenesis with Professor William James and Professor Richard Cornall
This talk was broadcast on Wednesday 13 May.
Watch the recording: https://youtu.be/mm7JCfhiptE
Professor William James, from Oxford’s Sir William Dunn School of Pathology, and Professor Richard Cornall, Head of the Nuffield Department of Medicine, talk about the University's research into how the COVID-19 virus behaves in humans. Professor James will be covering what his team are investigating and why, as well as his focus on building the Oxford SARS-CoV-2 virus facility, which is supporting a number of projects across the University.
Talk 3: Drug discovery with Professor Nicole Zitzmann
This talk was broadcast on Thursday 21 May.
Watch the recording: https://youtu.be/beb0nsXHr4Y
Professor of Virology and Director of the Glycobiology Institute, Nicole Zitzmann, talks about how her team are working with other groups across the globe to apply chemical principles and techniques to address the important biological questions around COVID-19, and what they’ve already learnt through the development and testing of existing drugs.
Talk 4: Immunology with Professor Paul Klenerman
This talk was broadcast on Wednesday 27 May.
Watch the recording: https://youtu.be/-hjQNyCyKSA
Professor Paul Klenerman, Sidney Truelove Professor of Gastroenterology at the Nuffield Department of Medicine, talks about the Oxford Immunology Network’s research into the immune response to COVID-19, including what they’ve learned so far about the detection of neutralising antibodies, antiviral T cells and innate immune responses.
Talk 5: COVID-19: misinformation and inequality, with Gina Neff and Rasmus Nielsen
Wednesday 3 June, 1:15-1:45pm.
This talk will be broadcast here: https://youtu.be/1Wv0VtkEpxM
The coronavirus pandemic has stressed the value of independent, professional journalism and has intensified concerns about misinformation worldwide. According to the International Fact-checking Network, COVID-19 is the biggest challenge fact-checkers have ever faced, with journalists debunking both claims spread anonymously on social media and statements from leading politicians. The pandemic has also exacerbated many social inequalities, with recent research showing that during lockdown mothers are doing, on average, more childcare and more housework than fathers who have the same work arrangements. A factsheet published recently by the Reuters Institute also shows that women (26%) are more likely to avoid news than men (18%), compounding existing gender inequalities in news use. Join Professors Gina Neff and Rasmus Nielsen to hear more about both of these issues.
Talk 6: The UK’s COVID-19 digital contact tracing app, with Christophe Fraser and Michael Parker
Wednesday 10 June, 12:30-1pm.
This talk will be broadcast here: https://youtu.be/NIHUlp9DPQI
Professor Christophe Fraser from the Nuffield Departments of Medicine and Population Health and Professor Michael Parker, Director of the Wellcome Centre for Ethics and Humanities and a member of the Steering Group of the Ethics in AI Institute, explain the epidemiology and ethics that have underpinned the development of the NHS mobile contact tracing app. Professor Fraser will summarise the science behind the epidemiological model city of 1 million inhabitants devised to inform the app’s configuration. Professor Parker will discuss the ethical considerations needed to foster well-founded public trust and confidence when deploying an app-based approach.
Talk 7: Post-COVID economy and a green recovery, with Peter Drobac and Aoife Haney
Friday 12 June, 12:15-12:45pm.
This talk will be broadcast here: https://youtu.be/Q2pazGEaOLE
Director of the Skoll Centre for Social Entrepreneurship, Peter Drobac, and Dr Aoife Haney, Research Lecturer in Innovation and Enterprise, discuss the economic and environmental impacts of the COVID-19 pandemic, and how policymakers can adapt to its effects. They'll explore the potential for strong alignment between the economy and the environment, and highlight policies which could stimulate economic growth while decreasing greenhouse gas emissions.
Talk 8: Vaccines with Professor Sarah Gilbert
The date, time and link for this talk will be available soon.
Professor of Vaccinology Sarah Gilbert currently leads the development of a vaccine (ChAdOx1 nCoV-19) against SARS-CoV-2, working with Oxford Vaccine Group and teams within the Jenner Institute. Professor Gilbert, who is also lead on the Jenner Institute’s influenza vaccine and emerging pathogens programme, has focused on pre-clinical influenza vaccine development, including developing viral vectored vaccines against emerging pathogens. She is an expert in all aspects of viral vectored vaccine development from design, through construction, quality control, pre-clinical testing, GMP manufacturing, regulatory and ethical applications to Phase I and II clinical trials.
More talks are being scheduled so bookmark this page and come back soon.